Getinge (GNGBF) Stock Price & Analysis
GNGBF Stock Chart & Stats
- Day’s Range
- $27.05 - $29.10
- 52-Week Range
- $18.26 - $29.10
- Previous Close
- $27.67
- Volume
- N/A
- Average Volume (3M)
- 32
- Market Cap
- $7.70B
- Enterprise Value
- $75.68B
- Total Cash (Recent Filing)
- $3.16B
- Total Debt (Recent Filing)
- $11.23B
- Price to Earnings (P/E)
- 26.7
- Beta
- 0.46
- Next Earnings
- Jan 26, 2027 (Est.)
- EPS Estimate
- 0.49
- Last Dividend Ex-Date
- Apr 23, 2026
- Dividend Yield
- 1.67%
Bulls Say, Bears Say
Bulls Say
Recurring Installed-Base Revenue
Revenue is diversified across capital equipment, service contracts, and consumables, while the installed base supports repeat demand over long equipment lifecycles. This mix can make customer relationships more durable and reduce reliance on any single purchase cycle.
Profitability Recovery
Improving net income and healthy operating profitability indicate that Getinge is converting its business activity into stronger earnings than in the recent comparison periods. If sustained, this recovery can support investment, service capability, and internally funded growth.
Improving Cash Generation
Stronger operating and free cash flow, together with substantial free-cash-flow conversion of net income, supports the quality of reported earnings. Better cash generation should improve Getinge’s ability to fund operations and meet obligations without relying solely on external financing.
Bears Say
Flat Revenue Trend
Limited revenue growth suggests that the recent earnings recovery is not yet being driven by broad top-line expansion. Without stronger demand or market share gains, Getinge may have less operating leverage and fewer opportunities to compound earnings over the next several quarters.
Margins Below Prior Peaks
Although current profitability is healthy, margins below earlier peak levels show that the recovery remains incomplete. Persistent underperformance versus those periods could constrain cash generation, investment capacity, and the company’s ability to absorb cost pressure while maintaining returns.
Rising Debt And Limited Flexibility
Higher debt alongside only moderate cash flow coverage reduces financial flexibility if operating conditions weaken. It may leave less capacity for aggressive deleveraging, acquisitions, or increased shareholder returns unless the recent improvement in profitability and cash generation persists.
Getinge News
GNGBF FAQ
What was Getinge’s price range in the past 12 months?
What is Getinge’s market cap?
When is Getinge’s upcoming earnings report date?
How were Getinge’s earnings last quarter?
Is Getinge overvalued?
Does Getinge pay dividends?
What is Getinge’s EPS estimate?
How many shares outstanding does Getinge have?
What happened to Getinge’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Getinge?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Getinge
Getinge AB, founded in 1904 and headquartered in Gothenburg, Sweden, is a prominent global supplier of medical technology solutions. The company's extensive portfolio is designed for critical healthcare environments, including operating rooms, intensive care units, and sterile processing facilities. Its operations are divided into three core segments: Acute Care Therapies, Life Science, and Surgical Workflows. Getinge offers a comprehensive array of specialized equipment and systems. This encompasses advanced solutions for sterile processing and containment, such as sterilizers, washers, isolators, and automated logistic systems. For the life sciences sector, they provide bioreactors, bioprocess control systems, and associated analytics tools. Within acute care and surgical settings, their offerings range from anesthesia machines, specialized monitoring systems, and various disposables, to instruments for cardiac surgery (like beating heart stabilizers), mechanical ventilation products, and extracorporeal life support (ECMO) solutions. Additionally, Getinge provides infrastructure for operating rooms, including lighting, tables, modular systems, and integrated management tools, alongside products for cleaning, disinfection, packaging, and comprehensive sterile supply management. Their product line further extends to diverse catheters (thoracic, endovascular), endoscopic vessel harvesting systems, patient flow and transport solutions, and specialized devices for vascular and cardiothoracic surgery. The company distributes its broad range of products globally through its proprietary sales companies, as well as via agents and distributors, serving markets across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region.
- Sector
- General
- Industry
- Medical - Devices
- CEO
- Mattias Perjos
- Employees
- 11,847
- Website
- www.getinge.com
- Address
- Lindholmspiren 7A, Gothenburg, VG, 417 56, SE
Getinge (GNGBF) Earnings & Revenues
GNGBF Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 14 | 4 | 4 |
| Technical Analysis | 2 | 4 | 4 |
| Moving Averages | 12 | 0 | 0 |
Similar Stocks
| Company | Price & Change | Follow |
|---|---|---|
| SE:BONEXBONESUPPORT HOLDING AB | ||
| SE:XVIVOXvivo Perfusion AB | ||
| SE:BACTI.BBactiguard Holding AB | ||
| SE:SECT.BSectra AB Class B | ||
| SE:SEDANASedana Medical AB |








